IL17A and metabolic dysfunction-associated steatotic liver disease: To further analyze the hepatotoxic signaling pathway of TEO, KEGG enrichment analysis was performed, including alcoholic liver disease, TNF signaling pathway, non‐alcoholic fatty liver disease, lipid and atherosclerosis, IL‐17 signaling pathway, C‐type lectin receptor signaling pathway, NF‐κB signaling pathway, bile secretion, toll‐like receptor signaling pathway and AMPK signaling pathway (Figure 6E).